FT-IR imaging for quantitative determination of liver fat content in non-alcoholic fatty liver by Kochan, Kamila et al.
Analyst
COMMUNICATION
Cite this: DOI: 10.1039/c5an00737b
Received 16th April 2015,
Accepted 15th May 2015
DOI: 10.1039/c5an00737b
www.rsc.org/analyst
FT-IR imaging for quantitative determination of
liver fat content in non-alcoholic fatty liver†
K. Kochan,a,b E. Maslak,a S. Chlopickia,c and M. Baranska*a,b
In this work we apply FT-IR imaging of large areas of liver tissue
cross-section samples (∼5 cm × 5 cm) for quantitative assessment
of steatosis in murine model of Non-Alcoholic Fatty Liver (NAFLD).
We quantiﬁed the area of liver tissue occupied by lipid droplets
(LDs) by FT-IR imaging and Oil Red O (ORO) staining for compari-
son. Two alternative FT-IR based approaches are presented. The
ﬁrst, straightforward method, was based on average spectra from
tissues and provided values of the fat content by using a PLS
regression model and the reference method. The second one – the
chemometric-based method – enabled us to determine the values
of the fat content, independently of the reference method by
means of k-means cluster (KMC) analysis. In summary, FT-IR
images of large size liver sections may prove to be useful for quan-
tifying liver steatosis without the need of tissue staining.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver dis-
order, primarily manifested by an increased accumulation of
lipids within the tissue, in the form of lipid droplets (LDs).1 In
the early stage of NAFLD it is diﬃcult to diagnose this disease
due to the lack of both: clear and specific symptoms as well as
diagnostic methods. The early stage of NAFLD (fatty liver) may
progress to non-alcoholic steatohepatitis (NASH) and cirrho-
sis,2 which finally leads to irreversible liver damage and
failure. It is not until the advanced stage of liver damage,
aﬀecting the functioning of the whole body, that the symptoms
of NAFLD (although still non-specific) become clearly visible.
Obviously, diagnosis of the disease at an advanced stage sig-
nificantly reduces the chances of successful therapy.
The importance of NAFLD relates not only to the fact that it
is widespread (WHO estimates that fatty liver aﬀects approxi-
mately 30% of the human population of the world)3 but more
importantly, because it represents a manifestation of a meta-
bolic syndrome4 that is associated with diabetes mellitus type
II and impose the increased risk of cardiovascular diseases.5
In fact, the association of hepatic steatosis with diabetes and
cardiovascular diseases is well established and was reported
numerous times.6,7 The nature of this relationship however,
just like the very emergence and development of fatty liver,
still remains unclear. NAFLD, often preceding the develop-
ment of mentioned diseases, is increasingly seen as their
common initial state, which can evolve in each of these.8
The lack of a good diagnostic method creates a need in this
field, which is not easy to accomplish, since an approach to
diagnose early NAFLD would need to be sensitive to small
changes of biochemical contents of the liver.
Fourier transform infrared (FT-IR) spectroscopy is a method
that possesses huge potential in the field of diagnostics.9–13
Primarily, it does not require any special sample preparation.
Moreover, this technique is adaptable to diﬀerent types of
preparation procedures, including formalin fixed and paraﬃn
embedded specimens, which are known to preserve the struc-
tural composition in a good way.10 Secondly, FT-IR is a sensi-
tive method to obtain information about the biochemical
composition of the sample without the use of stains (in the
case of which the number of dyes possible to be used on the
same sample is limited). Moreover, FT-IR is a relatively quick
technique of spectroscopic imaging that allows examination of
representative areas of samples. The use of infrared radiation
as a source of excitation minimalizes the possibility of a
destructive impact of the measurement on the sample.
Infrared imaging has been successfully applied for studies
of diﬀerent tissues and cells including liver,10,11 brain,12,13
lungs,14 cervix,15 and aorta.16 As for liver this technique was
mostly used to examine cancer.10,11 IR spectroscopy however is
perfectly suited to analyse tissue contents of lipids, as has
been repeatedly proven in various tissues.17–20 Both signals in
the high wavenumber range (2800–3100 cm−1) as well as
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within the fingerprint region (i.e. the band at approximately
1740 cm−1) are well suitable for demonstrating the presence of
lipids. In addition, IR spectra allowed for a detailed investi-
gation of the nature of lipid compounds of the sample, provid-
ing for example information on the presence of unsaturated
bonds or cholesterol and its esters.15 The quantitative
approach to tissue analysis with the use of FT-IR imaging is,
however, not common. Only a few examples can be found in
the literature.20 In addition, quantitative determination via
FT-IR requires supporting results, obtained from the other
method, as absolute quantification through spectral data itself
is not possible.21
The aim of this work was to develop a methodology for
infrared imaging-based quantitative analysis of liver steatosis
using a murine model of NAFLD and therefore elaborate new
tools applicable for fixed tissue sections.
In the present work we used a dietary mouse model of non-
alcoholic fatty liver. Fatty liver was induced in C57BL/6J male
mice by feeding for 15 weeks with a high fat diet (HFD), con-
taining 60 kcal% fat (Harlan Laboratories, Germany). For the
last 5 weeks of HFD feeding, some mice were subjected to anti-
steatotic treatment, so the liver taken from a group of 13
animals had varying degrees of steatosis. After 15 weeks of
HFD feeding the mice were euthanized by injection of keta-
mine (100 mg kg−1) with xylazine (10 mg kg−1). The livers were
collected immediately after euthanizing the animals and were
frozen in optimum cutting temperature (OCT) medium at
−80 °C. Direct preparation of tissue for measurement included
cutting it into slices of 10 µm thickness in a cryostat chamber
(Leica CM 1950) at −23 °C. Tissue sections were subsequently
placed on CaF2 slides and fixed with 4% buﬀered formalin
solution for 10 minutes. The remainders of the fixative were
washed out with distilled water (2 × 5 min).
FT-IR measurements on a macro scale were performed with
the use of a spectrometer FT-IR Varian 670 equipped with a
microscope (15× cassegrain objective) and a 128 × 128 MCT
Focal Plane Array detector. All spectra were recorded with a
spectral resolution of 8 cm−1 in the spectral range from 900 to
3800 cm−1 in the transmission mode, by accumulating 64
scans. The imaged areas were approximately ∼5 × 5 cm.
Data analysis was performed with the use of Varian Resolu-
tion Pro Software, as well as Cytospec and MatLab. The inte-
gration of the band areas was performed in Opus Software.
Data preprocessing included: baseline oﬀset correction, nor-
malisation to the amide I band (1620–1680 cm−1) and a
quality test (to remove pixels representing the background as
well as distorted) performed on the basis of sample thickness
criterion in the range 1620–1680 cm−1. K-means cluster analy-
sis was performed in the range 1420–1760 cm−1 with the use
of 2nd derivatives (calculated with Savitzky–Golay algorithm
and 9 smoothing points). The number of classes diﬀered
between samples, but typically not exceeding 4.
As a reference method histochemical staining with Oil Red
O was used. Oil Red O is a standard diazo dye for lipids and
triglycerides. The procedure of staining involved application of
solutions for a certain amount of time, according to the follow-
ing steps: deionized water (3 min), 60% isopropanol alcohol
(2 min), Oil Red O (30 min) and deionized water (1 min). After-
wards the slides with tissues were covered with glycerol gel.
The % of tissue covered by lipid droplets was calculated with
the Columbus Image Data Storage and Analysis System
(PerkinElmer, USA) adapted for the Oil Red O stained sections
algorithm.
Results and discussion
ORO staining
The first approach to analyse the obtained data was a general
assessment of the fat content within the liver tissue with the
use of a “gold standard” method – histochemical staining with
Oil Red O (ORO). Fig. 1 presents the results of ORO staining
on the basis of which the assessment of the level of steatosis
was made: representative stained sections with various con-
tents of the fat (Fig. 1A) and obtained results, expressed as a
percentage of the tissue surface occupied by the lipid droplets
(Fig. 1B).
As can be seen, the degree of fat content was quite diﬀerent
within the studied group (∼2–42%), as intended, and thus pro-
vided an appropriate series of samples to validate the use of
FT-IR for the liver fat content analysis. The ORO staining
results reflect well the content of fat within the tissue. On the
one hand, they allow for a rapid assessment of the overall con-
Fig. 1 (A) ORO stained sections (magniﬁcation 100×) from 3 represen-
tative samples with diﬀerent levels of steatosis (with the percentage of
fat speciﬁed under the photograph) along with (B) the level of steatosis
expressed as a % of tissue area occupied by lipid droplets. The percen-
tage values (given above each bar and below each photograph) were
calculated by Columbus Software.
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ditions of the organ, while on the other hand they enable a
more detailed, quantitative research.
FTIR based approaches
The presented approaches involved FT-IR imaging of the
whole liver tissue cross-sections. The condition for the correct-
ness of their application is imaging of the whole tissue sec-
tions. Even though a healthy liver is homogeneous, the
pathologically changed liver was featured by heterogeneity and
unevenly distributed lipid droplets in diﬀerent parts of the
liver tissue.
Approach 1: a PLS model based on average spectra for each
tissue section
The first FT-IR approach is based on obtaining average spectra
for each tissue section. After extraction of such spectra, the
removal of the baseline and the normalization to the amide I
band, two ratios of intensities were calculated: of the high
wavenumber range (2800–3100 cm−1) to the amide I band and
of the area of the band located at 1740 cm−1 (CvO stretching
vibration20) to the amide I band. Ratios calculated in such a
way, preceded by normalization of all spectra to the amide I
band, represent the content of lipids within each tissue in a
straightforward manner. Fig. 2 presents the calculated ratios
from FT-IR averaged spectra of whole tissues.
By comparing the IR-based results from Fig. 2A and B with
the ORO assessment, it can be seen that the trend of changes
between samples is well preserved by both chosen ratios.
However, the ORO-based approach presents the results in a
way that magnifies the diﬀerences between the content of
lipids in diﬀerent tissue sections. In the IR-based approach
the diﬀerences between the extreme samples do not appear to
be so big (compare the relationship between samples 3 and 6
in Fig. 1B, 2A and B). The reason for that is, however, very
simple. The appearance of lipid droplets in healthy liver is not
excluded entirely, as they can occur in healthy tissues as well,
but they are not present in high amounts. Therefore, the per-
centage of the tissue area occupied by LDs can vary practically
from none or very low to very high. Due to this, in the case of
the ORO assessment, the scale of the results varies between
0 and 100. The IR-based approach, on the other hand, involves
the use of spectra averaged across the tissue. In such a spec-
trum both chosen signals, the band at 1740 cm−1 and the
bands in the range 2800–3050 cm−1 will never be completely
absent.
In order to improve the chosen criterion, both ratios
(1740 cm−1/amide I and 2800–3050 cm−1/amide I) were calcu-
lated for healthy liver tissue sections, with the use of identical
pre-treatment of spectra. The results obtained for the whole
sample set were decreased by the values obtained for samples
of healthy liver (1740/amide I: 0.07 and 2800–3050/amide I:
0.46). The corrected FT-IR band ratios (Fig. 2C and D) repro-
duced the ORO results better and can be used to estimate the
level of steatosis.
Fig. 2 The values calculated from FT-IR spectra (obtained by averaging the whole tissue measurement), presenting the ratios of chosen bands: (A)
at 1740 cm−1 to the amide I band (1620–1680 cm−1) and (B) the high wavenumber range (2800–3050 cm−1) to the amide I band (1620–1680 cm−1).
Panels (C) and (D) represent the same data set, but the values are decreased by the value obtained for the control samples (livers from healthy mice).
The presented values were calculated for spectra normalised to the amide I band to reﬂect more strictly the diﬀerences between the levels of lipids
within the tissue.
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For the FT-IR averaged spectra of tissues a PLS regression
model for the prediction of the level of steatosis (percentage of
the tissue area occupied by LDs) was built. The data set was
divided into two: calibration and validation sets. Each of them
contained samples diﬀering in the level of steatosis. Diﬀerent
pre-treatment procedures and spectral ranges were tested, but
eventually the best results were obtained for the model where
the pre-treatment of spectra remained the same as for the cal-
culation of ratios and the spectral range of 1580–1780 cm−1
was included. The parameters of the PLS model (on the basis
of the calibration set) are presented in Table 1. The results of
prediction performed with the use of it on the validation
model are presented in Fig. 3 (and Table S1, ESI†).
The model allowed for a successful prediction of the per-
centage of tissue covered by lipid droplets, although the stan-
dard deviation appears to be higher for tissues with medium
developed steatosis. Nonetheless, the predicted values remain
in good agreement with the ORO-based results (see Table 2,
summarising the FT-IR based approaches).
Approach 2: the ratio of pixels assigned to the lipid class to all
pixels
The second possible FT-IR approach involves the use of entire
spectral images, obtained for large areas of tissue sections. By
performing cluster analysis (k-means) on the FT-IR images
obtained, it is possible to separate a class of clearly higher
lipid contents. Subsequently, analogously to the ORO-based
approach, by calculating the ratio of pixels assigned to the
lipid class to all pixels representing the tissue it is possible to
determine the percentage of tissue occupied by LDs. An
example of this approach is presented in Fig. 4.
This approach, however, is associated with a certain error,
especially in the case of microvesicular steatosis or any early
stage of LD development. This results from the droplet size
and shape. In cases of an early development or manifestation
in the form of microvesicular steatosis, the droplet size tends
to be below the spatial resolution of pixels in FT-IR images (∼5
× 5 µm2). Thus, the assessed value will be overestimated (when
the droplet is smaller than the pixel but takes more than 50%
of its area) or underestimated (if the droplet covers less than
50% of pixel area). This problem applies also to a more
advanced stage, when single LD occupies an area of several
pixels. Due to their round shape, droplets will never fit per-
fectly into the image constructed from square pixels. Moreover,
the cluster analysis approach does not allow (in the case of
attempts to develop a universal model) for a clear definition of
when a class can be classified as a tissue and when as a LD.
This is due to the fact that the lipid content (and therefore –
spectrum) within the tissue (excluding lipid droplets) is
diﬀerent for the tissues with advanced steatosis and without it
(or on early stage of development). In general, spectra of the
“non-lipid” classes from livers with advanced steatosis present
much more intense lipidic signals compared to “non-lipid”
classes from healthy livers. Therefore, a clear criterion for the
division between the lipid and non-lipid classes (i.e. a particu-
lar value of the lipid/protein ratio) that would be applicable for
all tissues, regardless of the level of steatosis development
cannot be defined. Each tissue should be rather considered
individually.
Despite potential sources of errors described above, with a
careful approach, it is possible to obtain the percentage values
of tissue occupied by LDs. These results still remain in good
correlation with the values obtained by the ORO-based
Table 1 Parameters of the PLS regression model
Parameter Value Parameter Value
Slope 0.9805945 R-square 0.9805948
Oﬀset 0.363441 RMSEC 2.0094995
Correlation 0.9902497 SEC 2.1482458
R2 (Pearson) 0.9805945 Bias −4.7684 × 10−7
Fig. 3 Results of prediction of the percentage of tissue occupied by
LDs performed with the use of a built PLS model for the validation set
(value – red line, standard deviation – blue squares). The PLS model is
based on FT-IR spectra averaged for whole tissue sections, in the range
1580–1780 cm−1.
Table 2 Results of the assessment of % of tissue occupied by LDs
obtained with all presented approaches: from ORO staining and from
FT-IR spectra: PLS-based and KMC-based analyses. The SD values for
the PLS-based approach are presented in Table S1 (ESI)
Sample
% of tissue occupied by LDs
PLS KMC ORO
Sample 1 6.49 6.33 5.35
Sample 2 11.45 8.52 7.86
Sample 3 1.04 1.97 2.33
Sample 4 11.09 10.24 11.87
Sample 5 18.67 18.96 16.37
Sample 6 39.47 38.05 40.9
Sample 7 41.05 43.38 42.37
Sample 8 35.70 32.8 30.37
Sample 9 1.04 3.66 4.07
Sample 10 17.10 18.93 16.29
Sample 11 29.71 26.2 25.69
Sample 12 15.14 15.29 15.7
Sample 13 19.46 21.81 19.64
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approach (Fig. 5 and Table 2). Therefore, this approach – like
the previous, based on average spectra – also appears to be
suitable for assessment of the degree of steatosis development.
Conclusions
FT-IR imaging is a technique with huge potential in the field
of the study of biological materials. The simplicity of sample
preparation and the complexity of the obtained results make it
a tool of choice for tissue studies. In addition, it provides a
possibility not only to examine bigger groups of samples but
also to investigate large areas, thereby eliminating both the
impact of individual variability and randomness of the selec-
tion of the investigated area. In the present work we applied
FT-IR imaging of large pieces of liver cross-sections for quanti-
tative determination of the steatosis that was performed on the
basis of percentage of liver tissue occupied by lipid droplets.
We presented two approaches: the first, based on the averaged
spectra of a tissue and the second, based on the KMC analysis
of each imaged specimen. Both approaches enabled us to
obtain results, which remain in a very good correlation with
ORO results and therefore allowed us to achieve the same
objective as ORO staining. In the case of spectroscopic
methods, however, the obtained experimental data can be
additionally analysed in terms of liver contents of other com-
ponents. In the first approach presented in this work, a simple
calculation of the ratio of lipid to protein bands (preceded by
normalisation to the amide I band) provided in a straight-
forward manner to quantify the liver lipid content. By the use
of a PLS regression model and results obtained with ORO
staining, it was possible to obtain explicit values. The second
approach proposed in this work allowed, in an analogous way
to the ORO-based method, to assess the percentage of tissue
aﬀected by pathological steatotic changes. It is worth adding
that the first approach did not require the use of any advanced
chemometric methods and was easier to implement in terms
of analysis. However, it did not allow us to determine the
absolute value of the fat liver content without the aid of
another technique. The second approach, in turn, required a
more time-consuming analysis, but it enabled us to determine
the absolute value of the fat content without the need of a
reference method. Altogether, FT-IR imaging of large areas of
liver cross-section seems to represent a powerful and reliable
method for the quantitative assessment of liver steatosis that
may prove to be useful to assess liver disease progression in
animal models of NAFLD as well as in patients.
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